Patent details

Basic Information

Publication number:

92636

Type:

SPC

SPC Type:

Medical

Basic Patent Number:

EP100014067

Legal Status:

Expired

Application number:

92636

First applicant's nationality:

Procedural language:

French

Marketing Authorization

1

Marketing Authorization Number:

BE424286-BE424295 - Edluar

Marketing Authorization Type:

Marketing Authorization Date:

18/07/2012

Marketing Authorization Status:

Accepted

Marketing Authorization Country:

Belgium (BE)

2

Marketing Authorization Number:

2012120233-2012120234 Zolpeduar 5mg/10mg

Marketing Authorization Type:

Marketing Authorization Date:

19/02/2013

Marketing Authorization Status:

Accepted

Marketing Authorization Country:

Luxembourg (LU)

Dates

Filing date:

20/01/2015

First Marketing Authorization date:

18/07/2012

Grant date:

20/03/2015

Activation date:

24/09/2019

Publication date:

20/03/2015

Lapsed date:

Expiration date:

Renunciation date:

Revocation date:

Annulment date:

Basic SPC Expiration:

24/09/2024

SPC Extension Expiration:

24/09/2024

Rejection date:

Withdrawal date:

Owner

From:

20/01/2015

 

 

Name:

Orexo AB

Address:

Box 303, 751 05 Uppsala, Sweden (SE)

Agent

Name:

OFFICE FREYLINGER S.A.

From:

20/01/2015

Address:

Boîte Postale 48, L-8001, STRASSEN, Luxembourg (LU)

To:

Inventor

1

Name:

Pettersson Anders

Address:

Sweden (SE)

2

Name:

Nyström Christer

Address:

Sweden (SE)

Publication

Bulletin

Bulletin Heading:

SPC3

Bulletin edition number:

2019/11

Publication date:

29/10/2019

Description:

Section E : Supplementary Protection certificates entered into force – IA publication

Annual Fees

Annual Fee Due Date:

Annual Fee Number:

Expected Payer:

Last Annual Fee Payment Date:

12/09/2023

Last Annual Fee Paid Number:

25

Last Annual Fee Paid Amount:

450 Euro

Payer:

CLARIVATE IP SERVICES LIMITED

Filing date	Document type	Number of pages